LEK-8827

LEK-8827, also known as 6-methyl-LEK-8842 or as 6-methyl-N-methyl-N-(2-propynyl)lysergamide, is a chemical compound of the lysergamide family.

Uses your system voice; voice and rate in settings.

Snapshot

≈ 1 min read

Names in other languages

No names in other languages are held for this entry yet.

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

LEK-8827, also known as 6-methyl-LEK-8842 or as 6-methyl-N-methyl-N-(2-propynyl)lysergamide, is a chemical compound of the lysergamide family. It is the 6-methyl derivative of LEK-8842 and is a quaternary ammonium compound.

The drug shows almost complete elimination of affinity for serotonin 5-HT 2 and α-adrenergic receptors compared to LEK-8842, with no affinity for serotonin 5-HT 2 receptors and slight but negligible affinity for α-adrenergic receptors. Its loss of activity was said to probably be due to the increased polarity of the molecule.

LEK-8827 was first described in the scientific literature by 1992. It was developed by the Slovenian pharmaceutical company LEK Pharmaceuticals.

Text derived from https://en.wikipedia.org/w/index.php?oldid=1364275651 under CC BY-SA 4.0; modifications have been made.

Sources cited in this revision

No external citation was extracted for this revision. That is a statement about the source, not a claim that none exists.